Trades of Eli Lilly shares were made on Trump’s behalf as drugmaker benefitted from his policies
Donald Trump had significant trades made on his behalf in Eli Lilly shares, benefiting from policies during his administration. Financial disclosures revealed trades worth between $220 million and $750 million in the first quarter of 2026. The Trump Organization stated that Trump does not directly manage these investments, which are handled by third-party financial institutions.
- ▪Eli Lilly shares worth up to $680,000 were acquired on Trump's behalf between January and March 2026.
- ▪The trades coincided with government actions that benefited Eli Lilly's weight-loss drugs.
- ▪Trump's investment holdings are managed by third-party financial institutions, according to the Trump Organization.
The Guardian — US files mainly under news. We currently carry 434 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | The Guardian — US |
| Canonical URL | https://www.theguardian.com/us-news/2026/may/19/trades-eli-lilly-shares-trump-drugmaker |
| Publication time | Tue, 19 May 2026 16:38:33 GMT |
| Retrieval time | 2026-05-19T16:44:57.864Z |
| Last seen | 2026-05-19T16:44:57.864Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | INdvsrXkmWRF |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
The logo for Eli Lilly And Co hangs at the entrance to the New York Stock Exchange after the opening bell on Wall Street on 11 May 2026 in New York City. Photograph: John Angelillo/UPI/ShutterstockView image in fullscreenThe logo for Eli Lilly And Co hangs at the entrance to the New York Stock Exchange after the opening bell on Wall Street on 11 May 2026 in New York City. Photograph: John Angelillo/UPI/ShutterstockDonald TrumpTrades of Eli Lilly shares were made on Trump’s behalf as drugmaker benefitted from his policiesFilings reveal $220m to $750m in trades on US president’s behalf in first quarter of 2026, including securities linked to largest US companiesAnna BettsTue 19 May 2026 12.38 EDTLast modified on Tue 19 May 2026 12.39 EDTSharePrefer the Guardian on GoogleHundreds of…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Guardian — US.
Discussion
0 commentsMore from The Guardian — US
